Novo Nordisk, which used to be the unchallenged king of GLP-1 weight-loss shots, has blown its lead over the past year, as evidenced by the Danish companys serious guidance cut last week
The real questions are harder
In a population without specific risk factors for thyroid cancer, the benefits of GLP-1 RAs will largely outweigh the harm. The European Medicines Agency in October 2023 announced that they did not find a causal link between GLP-1s and thyroid cancer after a months-long review
Quercetin ameliorates oxidative stressinduced cell apoptosis of seminal vesicles via activating Nrf2 in type 1 diabetic rats
its a metabolic reset for sustainable weight loss
Policy Lab has over 100,000 subscribers and welcomes more than 50,000 visitors each month who are searching for clinical trials and treatment options across a wide range of therapeutic areas